Infectious Diseases Clinical Trials

Clinical research brings the latest potential treatment options to the BayCare community, working together with willing participants to find new and better ways to tackle pressing health concerns. Enrollment periods on trials varies. While you may not see an opportunity today, an opportunity may be open in the near future. For more information on any of these trials, please submit your information under the trial opportunity listed or call 727-519-1904.
Enrolling Clinical Research Studies


Infectious Disease

GS-US-563-5925

A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)

PROMISE-US

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab (PROMISE-US)